Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 33-1328699 · Snapshot of IRS recognition, filing currency, financial health, and governance.
Promote networking between academic, industrial and investor members to know each other and contribute to the advancement of innovative science and technology to enable Peptide Drug discovery.
Principal Officer
Tomi Sawyer
Total Revenue
$0
FY2024
Total Expenses
$27K
FY2024
Net Assets
-$27K
Program Ratio
50.7%
expenses on programs
Employees
—
Volunteers
—
Board Members
—
Voting
—
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.